Ceapro Inc. Momentum Despite Sales Dip
Ceapro Inc (TSE:CZO) has released an update. Ceapro Inc. has announced a drop in Q1 2024 sales compared to the previous year, alongside significant...
Stay updated with breaking news from Ceapro Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ceapro Inc (TSE:CZO) has released an update. Ceapro Inc. has announced a drop in Q1 2024 sales compared to the previous year, alongside significant...
TORONTO, ON, May 01, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) announces that it has filed...
Ceapro Inc (TSE:CZO) has released an update. Ceapro Inc. experienced a challenging 2023 with a 49% decline in sales to $9.6M, attributed to a major...
– 2023 marked byCeapro’sachievement of key milestones and progress toward its next phase of growth
/PRNewswire/ -- The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024...